FDA approves Spark's gene therapy for rare form of blindness

Reuters India Tuesday, 19 December 2017 ()
(Reuters) - The U.S. Food and Drug Administration on Tuesday approved Spark Therapeutics Inc's treatment for a rare form of blindness, marking the first time the agency has approved a gene therapy for an inherited disease.
👓 View on full article
0
shares		Share on
FacebookShare on
TwitterPost on 
RedditShare by
Email
 
Source: CBS 3 Philly - < > Embed
News video: The FDA Approves Nation's First Gene Therapy

The FDA Approves Nation's First Gene Therapy 00:31

 The FDA approves the nation's first Gene Therapy treatment for a rare form of blindness.